2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Revenue | $186M | $248M | $221M | $143M | $99M |
Cost of Revenue | $101M | $126M | $116M | $72M | $38M |
Gross Profit | $85M | $122M | $106M | $70M | $61M |
Gross Profit % | 46% | 49% | 48% | 49% | 62% |
R&D Expenses | $8.1M | $9.8M | $6M | $4.6M | $0 |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Net Income | -$63M | -$235M | -$196M | -$75M | -$12M |
Dep. & Amort. | $552K | $7.3M | $7.5M | $3.9M | $1.9M |
Def. Tax | $22M | $194M | $0 | -$1.2M | $0 |
Stock Comp. | $23M | $29M | $15M | $8.3M | $0 |
Chg. in WC | $7.5M | -$19M | $20M | $16M | $11M |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Cash | $27M | $30M | $44M | $20M | $18M |
ST Investments | $0 | $0 | $0 | $0 | $0 |
Cash & ST Inv. | $27M | $30M | $44M | $20M | $18M |
Receivables | $5.7M | $10M | $4.5M | $4.2M | $3.8M |
Inventory | $32M | $63M | $44M | $20M | $14M |
Aterian reported a strong improvement in financial performance for 2024, with adjusted EBITDA losses reduced by 91% year-over-year to $2.1 million and net losses narrowed by 83.1% in Q4.
The company provided 2025 guidance, expecting net revenue between $104 million and $106 million, representing a 9%-12% pro forma growth, and targeting breakeven adjusted EBITDA despite the impact of tariffs.
Key growth drivers for 2025 include new product launches, expansion into additional channels like Target Plus and MercadoLibre, and geographic expansion into the UK.
Aterian announced a two-year $3 million share repurchase program, reflecting confidence in its undervalued stock and commitment to shareholder value.
The company expects a 10%-12% CAGR in revenue from 2025 to 2027, driven by continued product launches, omnichannel expansion, and entry into new international markets.